PMID: 6107599Nov 1, 1980Paper

Oestrogen use and survival in endometrial cancer

Lancet
J CollinsO Adams

Abstract

Of 860 women with endometrial cancer registered in a regional cancer treatment centre, 259 (30%) gave a history of oestrogen use for 6 months or more at some time before diagnosis, and 568 (66%) were non-users. OEstrogen use was associated with younger age, earlier stage, lower grade of tumour, less common myometrial invasion, and preferred treatment including radiation and hysterectomy. The 5-year survival of oestrogen users was 92 +/- 2% compared with 68 +/- 2% for non-users. Further analysis controlling for differences in the distribution of the variables associated with survival showed that for women who have endometrial cancer, the risk of any death for non-users is approximately 2-7 times greater than for oestrogen users, and the risk of death from endometrial cancer is 5.4 times greater for non-users. A history of oestrogen use is not associated with superior survival of women who have poorly differentiated tumours or myometrial invasion.

References

Jun 3, 1976·The New England Journal of Medicine·T M MackS E Brown
Jun 1, 1977·Obstetrics and Gynecology·T W McDonaldT A Gaffey
Jan 4, 1979·The New England Journal of Medicine·C M AntunesR Garcia
Aug 1, 1979·Gynecologic Oncology·P B UnderwoodM H Lutz
Mar 1, 1978·Annals of Internal Medicine·N S Weiss

❮ Previous
Next ❯

Citations

Oct 1, 1991·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·T L Bush
Feb 1, 1995·Obstetrics and Gynecology·D GradyD Petitti
Nov 1, 1995·Progress in Cardiovascular Diseases·I H Thorneycroft
Feb 19, 1994·Lancet·F E van LeeuwenF W Diepenhorst
Jan 1, 1993·Baillière's Clinical Endocrinology and Metabolism·T M Mack
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·W. G. McCluggageA. Al-Nafussi
May 1, 1993·British Journal of Obstetrics and Gynaecology·C T FitzgeraldR E Mansel
Jun 1, 1997·British Journal of Obstetrics and Gynaecology·W G McCluggageC M Hill
Jan 1, 1991·Annals of the New York Academy of Sciences·H KuramotoT Iida
Sep 30, 1994·Annals of the New York Academy of Sciences·C F Holinka
Dec 1, 1991·Baillière's Clinical Obstetrics and Gynaecology·T L Bush, K Miller-Bass
Mar 15, 1983·Cancer·S FranceschiG Tognoni
Aug 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R EstruchA Urbano-Márquez
May 6, 2006·American Journal of Epidemiology·Jocelyn M WeissNoel S Weiss
Jan 1, 1984·Upsala Journal of Medical Sciences·I PerssonB Pettersson
Sep 15, 1992·Postgraduate Medicine·P B Marshburn, B R Carr
Jun 1, 1994·Australian Journal of Public Health·E GeelhoedR Prince
Jun 1, 1981·Journal of the Royal Society of Medicine·J Collins
May 13, 2015·Cancer Causes & Control : CCC·Ashley S FelixLouise A Brinton
Nov 24, 1984·The Medical Journal of Australia·B K Armstrong
Oct 2, 2002·Obstetrics and Gynecology Clinics of North America·John A Collins, James J Schlesselman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.